Genetics-Based Medication Management
Genomind helps patients and providers tailor medications based on one’s unique genetics, lifestyle, and environment.
Evolving how we
prescribe medicine
In the US each year, providers write billions of prescriptions for over 20,000 FDA-approved drugs, often relying on a “trial and error” approach to manage a patient’s medications.
With Genomind PGx reports, providers pair their existing clinical expertise with a precise and personalized treatment plan based on a patient’s genetics.
Optimizing treatment can take us from harm to healing
Every year people are injured or abandon medications altogether due to side effects or lack of efficacy.
3.2MM
>50%
$528B
52%
Deliver targeted and personalized care
Genomind brings critical prescribing data into one integrated platform, so you can easily manage medications for individual patients or large populations with precision.
Precision Medicine Software
Identify gene-drug risks while and adjust to safer alternatives.
Population Health Assessment
Stratify populations for potential gene-drug interaction risks.
Coming Soon
Why 20,000 health providers and over 400,000 patients have chosen Genomind PGx reports and software
Improving the patient care experience
Associated with reducing hospitalizations and individual healthcare costs
What's new in precision medicine
Learn in person, virtually, or at your own pace through our education platform, Genomind 360.
Department of Defense Awards Genomind Contract for Pharmacogenomics Consulting
KING OF PRUSSIA, Pa.–(BUSINESS WIRE)–Genomind, a leader in precision medicine and pharmacogenomic (PGx) testing, today announced it has been awarded a contract to support the
[WEBINAR] Genetics-Based Medication Management: A Powerful Tool for Resident Care
Nursing homes need ways to optimize case management, especially for residents with mental health conditions like schizophrenia and dementia-related symptoms.
A genetics-based approach to medication management offers a clear solution – at no additional cost to the facility.
Evexia Diagnostics Partners with Genomind to Offer Cutting-Edge Pharmacogenetic Testing to Clinicians
Genomind’s new partnership with Evexia Diagnostics expands access to its pharmacogenetic testing, helping more clinicians personalize treatments and improve patient outcomes through genetic insights.